ConductScience.org, home

Paper39458609

Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy.

Lekešytė B and 11 others. Pharmaceutics, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy. Papers, record 39458609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39458609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Application of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy.
PubMed
Journal
Pharmaceutics
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.13, provisional
iCite
Revised in PubMed
2024-10-28
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lekešytė BBarborahttps://orcid.org/0000-0002-6339-8234
2Mickevičiūtė EEglėhttps://orcid.org/0009-0006-2656-2185
3Malakauskaitė PPaulina
4Szewczyk AAnnahttps://orcid.org/0000-0003-0934-9180
5Radzevičiūtė-Valčiukė EEivinahttps://orcid.org/0000-0003-4588-7576
6Malyško-Ptašinskė VVeronikahttps://orcid.org/0000-0002-2438-5713
7Želvys AAugustinashttps://orcid.org/0000-0002-1952-0431
8German NNatalijahttps://orcid.org/0000-0002-7779-529X
9Ramanavičienė AAlmirahttps://orcid.org/0000-0001-5864-0359
10Kulbacka JJulita
11Novickij JJurij
12Novickij VVitalijhttps://orcid.org/0000-0001-6147-956X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
S-MIP-24-580Research Council of LithuaniaPubMed

Source PubMed

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131869699Contactless electroporation induced by high intensity pulsed electromagnetic fields via distributed nanoelectrodes.Bioelectrochemistry2020https://conductscience.org/library/papers/31869699PubMed
228391185Bipolar Microsecond Pulses and Insulated Needle Electrodes for Reducing Muscle Contractions During Irreversible Electroporation.IEEE Trans Biomed Eng2017https://conductscience.org/library/papers/28391185PubMed
336077875Electrochemotherapy: An Alternative Strategy for Improving Therapy in Drug-Resistant SOLID Tumors.Cancers (Basel)2022https://conductscience.org/library/papers/36077875PubMed
436551739High-Frequency Nanosecond Bleomycin Electrochemotherapy and its Effects on Changes in the Immune System and Survival.Cancers (Basel)2022https://conductscience.org/library/papers/36551739PubMed
516545779Nanosecond pulsed electric fields cause melanomas to self-destruct.Biochem Biophys Res Commun2006https://conductscience.org/library/papers/16545779PubMed
632980738Electrophoresis-assisted accumulation of conductive nanoparticles for the enhancement of cell electropermeabilization.Bioelectrochemistry2021https://conductscience.org/library/papers/32980738PubMed
715267418Plasmon hybridization in spherical nanoparticles.J Chem Phys2004https://conductscience.org/library/papers/15267418PubMed
830021498ESOPE-Equivalent Pulsing Protocols for Calcium Electroporation: An In Vitro Optimization Study on 2 Cancer Cell Models.Technol Cancer Res Treat2018https://conductscience.org/library/papers/30021498PubMed
926271592Magnetic nanoparticle-based drug delivery for cancer therapy.Biochem Biophys Res Commun2015https://conductscience.org/library/papers/26271592PubMed
1018978447Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies.Phys Med Biol2008https://conductscience.org/library/papers/18978447PubMed
1137630998Calcium Electrochemotherapy for Tumor Eradication and the Potential of High-Frequency Nanosecond Protocols.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37630998PubMed
1221900067Equivalent pulse parameters for electroporation.IEEE Trans Biomed Eng2011https://conductscience.org/library/papers/21900067PubMed
1337111663Improving NonViral Gene Delivery Using MHz Bursts of Nanosecond Pulses and Gold Nanoparticles for Electric Field Amplification.Pharmaceutics2023https://conductscience.org/library/papers/37111663PubMed
1425229176Electroporation in cancer therapy without insertion of electrodes.Phys Med Biol2014https://conductscience.org/library/papers/25229176PubMed
1533743336Electroporation with nanosecond pulses and bleomycin or cisplatin results in efficient cell kill and low metal release from electrodes.Bioelectrochemistry2021https://conductscience.org/library/papers/33743336PubMed
1624749393Gold nanoparticles enhanced electroporation for mammalian cell transfection.J Biomed Nanotechnol2014https://conductscience.org/library/papers/24749393PubMed
1726355870Mitigation of impedance changes due to electroporation therapy using bursts of high-frequency bipolar pulses.Biomed Eng Online2015https://conductscience.org/library/papers/26355870PubMed
1817668934Mathematical modeling of irreversible electroporation for treatment planning.Technol Cancer Res Treat2007https://conductscience.org/library/papers/17668934PubMed
1928260889Gold nanoparticles and electroporation impose both separate and synergistic radiosensitizing effects in HT-29 tumor cells: an in vitro study.Int J Nanomedicine2017https://conductscience.org/library/papers/28260889PubMed
2038612865Gold Nanoparticles (AuNPs)-Toxicity, Safety and Green Synthesis: A Critical Review.Int J Mol Sci2024https://conductscience.org/library/papers/38612865PubMed

See all 30 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42883690Advancing Electrochemotherapy in Melanoma and Non-Melanoma Skin Cancer: From Clinical Practice to Emerging Frontiers.Int J Mol Sci2026https://conductscience.org/library/papers/42883690PubMed
41463389Gold Nanoparticles-Enhanced Gene Transfer Driven by MHz-Frequency Nanosecond Pulsed Electric Fields.Biomolecules2025https://conductscience.org/library/papers/41463389PubMed
41373426Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions.Int J Mol Sci2025https://conductscience.org/library/papers/41373426PubMed
40870986Limited Efficacy of Nanoparticle-Assisted Electroporation for Membrane Permeabilization and Gene Electrotransfer.Pharmaceutics2025https://conductscience.org/library/papers/40870986PubMed
39591094Gold Nanoparticles in Nanomedicine: Unique Properties and Therapeutic Potential.Nanomaterials (Basel)2024https://conductscience.org/library/papers/39591094PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39458609

GET https://conductscience.org/api/papers/v1/39458609/references?page=2